Last reviewed · How we verify

NCT05362383

Use of TENS for the Recovery of Oral Function After Orthognathic Surgery

Completed NA Last updated 11 May 2022
What this trial tests

NA trial testing transcutaneous electrical nerve stimulation (TENS):Enraf Nonius® S82 model in Orthognathic Surgery in 47 participants. Completed in 15 January 2020.

Timeline
1 February 2013
Primary endpoint
18 May 2018
15 January 2020

Quick facts

Lead sponsorUniversidad Complutense de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment47
Start date1 February 2013
Primary completion18 May 2018
Estimated completion15 January 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

Adults 22 to 65, any sex, with Orthognathic Surgery or Physiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oral functions of patients are markedly diminished immediately after orthognathic surgery, and novel approaches are needed to accelerate their recovery. The aim of this study is to examine the usefulness of weekly applications of transcutaneous electrical nerve stimulation (TENS) for this purpose, based on evidence of its effectiveness in other types of patients with muscle alterations. The main objective is to determine whether weekly TENS applications can increase the bite force and jaw opening in patients undergoing orthognathic surgery and decrease their pain and inflammation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of Transcutaneous Electrical Nerve Stimulation (TENS) for the Recovery of Oral Function after Orthognathic Surgery.
    Cacho A, Tordera C, Colmenero C. · · 2022 · cited 7× · PMID 35743339 · DOI 10.3390/jcm11123268

Verify or expand the search:

Other recruiting trials for Orthognathic Surgery

Currently open trials in the same condition.

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05362383.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing